Using a 577-nm diode laser to treat non-inflammatory acne
Effectiveness and Safety of 577-nm Diode Laser in the Treatment of Non -Inflammatory Acne
This study is testing if a special laser can safely help people with non-inflammatory acne, like blackheads, feel better and improve their skin.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Sponsor | Al-Azhar University Academic / other |
| Locations | 1 site (Asyut, Assuit) |
| Trial ID | NCT06909344 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety and effectiveness of a 577 nm diode laser specifically for treating non-inflammatory acne, which primarily manifests as comedones. Acne vulgaris is a common skin condition affecting many adolescents and young adults, often leading to psychological distress and scarring. The study aims to provide an alternative treatment option that may improve patient compliance compared to traditional topical and oral medications. Participants will undergo laser treatment to assess its impact on acne lesions and overall skin health.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18-40 with at least 10 comedonal lesions on both halves of their face.
Not a fit: Patients with systemic diseases affecting healing, photosensitivity, or those who are pregnant or have had recent acne treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could offer a more effective and less burdensome option for patients suffering from non-inflammatory acne.
How similar studies have performed: While laser treatments for inflammatory acne have shown success, the specific use of a 577 nm diode laser for non-inflammatory acne is less established and may represent a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with acne comedones * Patients' ages range from 18-40 years. * Minimum 10 comedonal lesions on both half of the face Exclusion Criteria: * Patients with systemic disease interfere with healing. * Patients with Photosensitivity. * Pregnant or lactating females. * Previous topical, systemic, laser, surgical treatment and comedogenic drugs in the last 3 months. * Skin cancer or suspicious lesions.
Where this trial is running
Asyut, Assuit
- Azhar Assuit university hospital — Asyut, Assuit, Egypt (Recruiting)
Study contacts
- Study coordinator: Hala Hasan Shehata, resident of dermatology
- Email: halahassan543@gmail.com
- Phone: +201142490157
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.